(PharmaNewsWire.Com, March 02, 2021 ) The report "EMEA 3D CBCT/Cone Beam CT Systems Market by Application (Dental (Oral and Maxillofacial Surgery, Implantology, Orthodontic, Endodontic) and Non-Dental (Radiology, ENT)), End User (Hospitals and Clinics, Diagnostic Centres) - Forecast to 2023", The EMEA 3D CBCT systems market is expected to reach USD 300.4 Million by 2023 from an estimated USD 194.3 Million in 2018, at a CAGR of 9.0%. With increasing disposable incomes, rising healthcare expenditure, and the availability of health insurance, the willingness to undergo expensive cosmetic procedures in various countries has increased. Moreover, the rising expenditure on treatments for appearance enhancements is driving the demand for dental products in the market.
Browse 74 market data Tables and 17 Figures spread through 115 Pages and in-depth TOC on "EMEA 3D CBCT/Cone Beam CT Systems Market - Forecast to 2023"
By application, the dental segment accounted for the largest share of the EMEA 3D CBCT systems market in 2017
On the basis of application, the market is broadly segmented into dental and non-dental applications. The dental applications segment further subsegmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications. The non-dental applications segment is subsegmented into ENT and radiology. The dental application segment accounted for the largest share of EMEA 3D CBCT systems market in 2017. Large geriatric population in the European countries, technological enhancements, wide adoption of 3D CBCT systems in dental implant procedures, and the growing focus on the evaluation of post-treatment cases are factors attributed to the large share of dental application.
By type, ENT segment accounted for the largest share of the non-dental application market in 2017
Based on the type, the non-dental application market is further segmented into ENT and radiology. In 2017, ENT segment accounted for the largest share of this market. This dominant share is attributed to the increasing use of CBT imaging in the diagnosis of ENT disorders due to advantages such as high spatial resolution, better visibility of small details, lower radiation exposure compared to traditional CT, patient convenience during examination, and compatibility of CBCT systems with surgical navigation/image-guided surgery systems during ear surgeries.
Europe dominated the market in 2017
Europe accounted for the largest share of the EMEA 3D CBCT systems market in 2017, followed by the Middle East and Africa. The largest share of the European region is mainly attributed to the rising geriatric population, increasing awareness about oral healthcare, rising incidence of dental diseases, growing demand for advanced cosmetic dental procedures, growing dental tourism in some European countries, and the increasing number of dental clinics and hospitals in the region.
The key players in the EMEA 3D CBCT systems market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
